Possible new Lycia Therapeutics shares

LYCADilution

Last raise Oct 23, 2026, 424B4: 17.6M shares at $18.00, $318M gross

Known so far: 17.6M possible new shares · no effective shelf · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today none, no effective shelf
How this is worked out

Shelf room: none. No shelf registration on EDGAR was declared effective in the last 3 years, so a sale needs a new registration or a private placement.

What could become new Lycia Therapeutics (LYCA) shares, from the S-1 and 424B prospectus covers we have read.

Read so far: the prospectus covers below. Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: S-1 registration filings.